A high-efficiency particle-filter air purifier is a room device trapping airborne particles. Trials show a small drop in the upper blood pressure reading, mainly with raised pressure, plus fewer symptoms in smoking-related lung disease and less allergy medication. Fewer infections are not supported; asthma results are inconsistent. Gains are largest in polluted homes with well-sized, continuously run units. Main risks: add-on features, fan noise, one pregnancy trial's unexplained early-birth signal. (Full Review)
| Marker | Target | Why |
|---|---|---|
| Home systolic/diastolic blood pressure | Below 120/80 mmHg | Main blood pressure benefit |
| Indoor PM2.5 (consumer air monitor) | At or below 5 µg/m³ yearly and 15 µg/m³ daily average | Confirms the purifier lowers exposure |
| High-sensitivity C-reactive protein (hs-CRP) | Below 1.0 mg/L | Modest inflammation marker shift |
| Ozone near units with add-on modules (consumer ozone monitor) | At or below 0.050 ppm | Safety check: a higher reading stops use of the module |
| COPD or asthma symptom score (COPD Assessment Test or Asthma Control Questionnaire) | No established target; change from own baseline | Respiratory symptom benefit |
Cadence: Baseline before starting; indoor PM2.5 in week 1, then monthly; home blood pressure as a one-week series after 1 month, then every 3–6 months; symptom scores monthly for the first 3 months; hs-CRP after 3 months, then yearly; ozone in week 1 and whenever settings change